安济盛生物医药技术（广州）有限公司地处广州科学城，是一家专注于骨骼肌肉关节等疾病的创新药物研发企业。公司同时在美国加州运营。公司的创始人及核心团队拥有多年在海外及国内大型跨国公司的药物研发和管理经验。公司拥有专业技能的新药靶标的研发团队，精通骨科疾病的病理生理学，运用遗传学和分子生物学前沿科学发现新的机理和信号传导通路及之间的互相作用，识别新的药物靶点，结合计算机辅助设计新型生物药物和小分子药物。公司产品的开发模式包括内部研发、与学术单位和全球业界研究机构建立外部合作等，服务于有需要的患者。公司的文化和工作环境非常开放、包容，具有人文关怀。欢迎有专业技能、积极乐观、上进和有团队合作精神的人士加入我们的团队。
我们的使命: 致力研发突破性创新药物，造福重症肌肉骨骼疾病患者！

Located in Guangzhou Science City, Angitia Biopharmaceuticals is an innovative biotech focusing on the discovery and development of novel drugs for serious bone, muscle and joint diseases. Angitia also has operation site in California, US. The founder and the core team members of Angitia are seasoned scientific leaders in new drug discovery, development and management from both overseas and domestic large multinational companies. The company has built an organization distinguished by world-class scientists with talents that proficient in the pathophysiology of musculoskeletal diseases. We utilize cutting-edge technologies of genetics and molecular biology to uncover new mechanisms, signal transduction pathways and their interactions combined with computer aided drug design to identify new drug targets, and to discover and develop new biological and small molecule medicines.  The company is committed to serving patients in need by carrying out innovative science includes internal research and external collaborations with academics and global biopharmaceutical companies. We are seeking people who are competent, ambitious and great team players to join our vibrant group.
Our mission is to discover, develop and commercialize breakthrough therapeutics that address the key unmet medical needs of serious musculoskeletal diseases.